INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 118 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,000 | -75.0% | 6,154 | +1.5% | 0.00% | – |
| Q1 2016 | $32,000 | -8.6% | 6,061 | +34.2% | 0.00% | – |
| Q4 2015 | $35,000 | -31.4% | 4,515 | -25.0% | 0.00% | – |
| Q3 2015 | $51,000 | +168.4% | 6,022 | +252.4% | 0.00% | – |
| Q2 2015 | $19,000 | 0.0% | 1,709 | +28.5% | 0.00% | – |
| Q1 2015 | $19,000 | -13.6% | 1,330 | +0.2% | 0.00% | – |
| Q4 2014 | $22,000 | 0.0% | 1,327 | -17.6% | 0.00% | – |
| Q3 2014 | $22,000 | +15.8% | 1,610 | +5.3% | 0.00% | – |
| Q2 2014 | $19,000 | +18.8% | 1,529 | +10.7% | 0.00% | – |
| Q1 2014 | $16,000 | -15.8% | 1,381 | +2.8% | 0.00% | – |
| Q4 2013 | $19,000 | -76.8% | 1,343 | -71.3% | 0.00% | -100.0% |
| Q3 2013 | $82,000 | +105.0% | 4,680 | +91.6% | 0.00% | – |
| Q2 2013 | $40,000 | – | 2,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |